Mark Jason Heath Ellison, Chief Development Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 610 shares at $20.26 ($12K) on 2023-01-27, disclosed to the SEC on 2023-01-31.
Seasonal sale ($12k) by Chief Development Officer — this insider has traded OPNT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |